Latest Breaking News On - Established brand pharmaceutical products - Page 1 : comparemela.com

ANI Pharmaceuticals exceeded Q1 Non-GAAP earnings expectations and raised its guidance to $385-$410 million. See why I rate ANIP stock a Strong Buy here.

New jerseyUnited statesAlpha dulan lokuwithanaAlpha quantCompany financialsOther pharmaceutical servicesPharmaceuticals incAni pharmaceuticals incGeneric pharmaceutical productsEstablished brand pharmaceutical productsRare disease pharmaceuticalCompetitive generic therapyAbbreviated new drug applicationsNitrofurantoin oral suspensionColestipol hydrochloride tabletsSeeking alpha